Stockreport

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections

ACHAOGEN  (AKAO) 
Last achaogen earnings: 3/28 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.achaogen.com/investor-overview
PDF SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials [Read more]